NO20031597L - Medisinske aerosolformuleringer - Google Patents

Medisinske aerosolformuleringer

Info

Publication number: NO20031597L
Authority: NO; Norway
Prior art keywords: aerosol formulations; medical aerosol; medical; formulations; aerosol
Prior art date: 2000-10-09

Application number

NO20031597A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031597D0 (no

Inventor

Lesley Mckenzie

James T Lister

Philip Anthony Jinks

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-09

Filing date

2003-04-08

Publication date

2003-05-30

2000-10-09 Priority claimed from GBGB0024711.4A external-priority patent/GB0024711D0/en

2003-04-08 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2003-04-08 Publication of NO20031597D0 publication Critical patent/NO20031597D0/no

2003-05-30 Publication of NO20031597L publication Critical patent/NO20031597L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

NO20031597A 2000-10-09 2003-04-08 Medisinske aerosolformuleringer NO20031597L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0024711.4A GB0024711D0 (en)	2000-10-09	2000-10-09	Medicinal aerosol formulations
GBGB0122512.7A GB0122512D0 (en)	2000-10-09	2001-09-18	Medical aerosol formations
PCT/US2001/030575 WO2002030394A2 (fr)	2000-10-09	2001-10-01	Formulations medicinales en aerosol

Publications (2)

Publication Number	Publication Date
NO20031597D0 NO20031597D0 (no)	2003-04-08
NO20031597L true NO20031597L (no)	2003-05-30

Family

ID=26245133

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031597A NO20031597L (no)	2000-10-09	2003-04-08	Medisinske aerosolformuleringer

Country Status (17)

Country	Link
EP (1)	EP1324749B1 (fr)
JP (1)	JP5021149B2 (fr)
CN (1)	CN1635870A (fr)
AR (1)	AR030862A1 (fr)
AT (1)	ATE320242T1 (fr)
AU (2)	AU1131102A (fr)
CA (1)	CA2425035A1 (fr)
CZ (1)	CZ2003983A3 (fr)
DE (1)	DE60118021T2 (fr)
ES (1)	ES2260299T3 (fr)
HU (1)	HUP0302311A3 (fr)
IL (1)	IL155088A0 (fr)
MX (1)	MXPA03002991A (fr)
NO (1)	NO20031597L (fr)
NZ (1)	NZ525054A (fr)
PL (1)	PL199420B1 (fr)
WO (1)	WO2002030394A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1337239B2 (fr)	2000-11-30	2015-11-25	Vectura Limited	Particules servant dans une composition pharmaceutique
DK1337240T4 (en)	2000-11-30	2015-01-05	Vectura Ltd	A process for the preparation of particles for use in a pharmaceutical composition
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0207906D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
JP2005536538A (ja) *	2002-08-23	2005-12-02	シェーリング　コーポレイション	薬学的組成物
US7109247B2 (en) *	2003-05-30	2006-09-19	3M Innovative Properties Company	Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) *	2003-05-30	2008-12-02	3M Innovative Properties Company	Stabilized aerosol dispersions
JP2006527237A (ja)	2003-06-13	2006-11-30	アルタナ　ファルマ　アクチエンゲゼルシャフト	ホルモテロールと及びシクレソニドの組合せ物
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
PL1670482T5 (pl)	2003-09-16	2022-10-03	Covis Pharma Gmbh	Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
GB0323684D0 (en)	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
CA2581999C (fr) *	2004-10-12	2013-04-23	Generics (Uk) Limited	Preparation de formulations d'aerosol
EP1949891A1 (fr) *	2004-10-12	2008-07-30	Generics (UK) Limited	Procédé pour la préparation de formules à suspension pour aérosol, caractérisé en ce que les particles soient formées par précipitation à l'intérieur d'un récipient
NZ556709A (en)	2005-02-10	2009-09-25	Glaxo Group Ltd	Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
CN100435784C (zh) *	2005-07-25	2008-11-26	管晓虹	含有和包封中药成分的无机盐纳米粒子的制备方法
CN100335038C (zh) *	2005-07-25	2007-09-05	江桥	含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法
DE102006040535A1 (de) *	2006-08-30	2008-03-13	Beiersdorf Ag	Aerosolzubereitung umfassend Peloide
CN101380309B (zh) *	2007-09-03	2012-05-09	李浩莹	一种定量吸入气雾剂及其制备方法
GB0918149D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
AR079451A1 (es)	2009-12-18	2012-01-25	Nycomed Gmbh	Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
JP2014519519A (ja)	2011-06-15	2014-08-14	タケダゲゼルシャフトミットベシュレンクテルハフツング	新規３，４，４ａ，１０ｂ−テトラヒドロ−１Ｈ−チオピラノ［４，３−ｃ］イソキノリン化合物
AR086915A1 (es)	2011-06-17	2014-01-29	Nycomed Gmbh	Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene
WO2018069210A1 (fr)	2016-10-10	2018-04-19	Takeda Gmbh	Tétrahydrofuro [3,4-c] isoquinolines en tant qu'inhibiteurs de pde4
CN109464429B (zh) *	2018-12-13	2021-04-27	上海方予健康医药科技有限公司	一种吸入压力定量气雾剂药物组合物及其制备方法
CN110755414A (zh) *	2019-11-12	2020-02-07	南京华盖制药有限公司	一种酒石酸阿福特罗气雾剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9001635D0 (en) *	1990-01-24	1990-03-21	Ganderton David	Aerosol carriers
EP0810853B1 (fr) *	1995-02-24	2004-08-25	Elan Pharma International Limited	Aerosols contenant des dispersions de nanoparticules
US5747001A (en) *	1995-02-24	1998-05-05	Nanosystems, L.L.C.	Aerosols containing beclomethazone nanoparticle dispersions

2001
- 2001-10-01 HU HU0302311A patent/HUP0302311A3/hu unknown
- 2001-10-01 EP EP01979338A patent/EP1324749B1/fr not_active Expired - Lifetime
- 2001-10-01 NZ NZ525054A patent/NZ525054A/en unknown
- 2001-10-01 IL IL15508801A patent/IL155088A0/xx unknown
- 2001-10-01 CA CA002425035A patent/CA2425035A1/fr not_active Abandoned
- 2001-10-01 CN CNA018169171A patent/CN1635870A/zh active Pending
- 2001-10-01 ES ES01979338T patent/ES2260299T3/es not_active Expired - Lifetime
- 2001-10-01 CZ CZ2003983A patent/CZ2003983A3/cs unknown
- 2001-10-01 AU AU1131102A patent/AU1131102A/xx active Pending
- 2001-10-01 AU AU2002211311A patent/AU2002211311B2/en not_active Ceased
- 2001-10-01 PL PL361135A patent/PL199420B1/pl not_active IP Right Cessation
- 2001-10-01 WO PCT/US2001/030575 patent/WO2002030394A2/fr not_active Ceased
- 2001-10-01 AT AT01979338T patent/ATE320242T1/de not_active IP Right Cessation
- 2001-10-01 DE DE60118021T patent/DE60118021T2/de not_active Expired - Lifetime
- 2001-10-01 MX MXPA03002991A patent/MXPA03002991A/es unknown
- 2001-10-01 JP JP2002533837A patent/JP5021149B2/ja not_active Expired - Fee Related
- 2001-10-09 AR ARP010104722A patent/AR030862A1/es not_active Application Discontinuation
2003
- 2003-04-08 NO NO20031597A patent/NO20031597L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP5021149B2 (ja)	2012-09-05
WO2002030394A3 (fr)	2003-01-30
PL361135A1 (en)	2004-09-20
PL199420B1 (pl)	2008-09-30
NZ525054A (en)	2004-11-26
ATE320242T1 (de)	2006-04-15
NO20031597D0 (no)	2003-04-08
WO2002030394A2 (fr)	2002-04-18
CZ2003983A3 (cs)	2003-09-17
CN1635870A (zh)	2005-07-06
HUP0302311A2 (hu)	2003-10-28
DE60118021T2 (de)	2006-10-26
HUP0302311A3 (en)	2006-07-28
CA2425035A1 (fr)	2002-04-18
AR030862A1 (es)	2003-09-03
MXPA03002991A (es)	2004-05-05
IL155088A0 (en)	2003-10-31
AU1131102A (en)	2002-04-22
AU2002211311B2 (en)	2006-08-31
JP2004510808A (ja)	2004-04-08
EP1324749A2 (fr)	2003-07-09
DE60118021D1 (de)	2006-05-11
ES2260299T3 (es)	2006-11-01
EP1324749B1 (fr)	2006-03-15

Publication	Publication Date	Title
NO20031597D0 (no)	2003-04-08	Medisinske aerosolformuleringer
DK1317177T3 (da)	2004-12-20	Desinficerende formuleringer
AR028291A1 (es)	2003-04-30	Formulaciones oftalmicas
DE10192161T1 (de)	2002-09-05	Medizinischer Führungsdraht
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
EE05421B1 (et)	2011-06-15	Fulvestrandi formulatsioonid
DK1199054T3 (da)	2004-09-27	Væskefrakturhånddel
DE50104720D1 (de)	2005-01-05	Desodorierende Zubereitungen
NO20025578D0 (no)	2002-11-21	Medisinsk innretning
PL364773A1 (pl)	2004-12-13	Inhalator dozujący ksynafonian salmeterolu
DK1274364T3 (da)	2007-05-21	Medicinsk implantat
FR2815535B1 (fr)	2003-01-24	Implant pediculaire
DK1441587T3 (da)	2006-05-22	Pesticidformuleringer
ATE263487T1 (de)	2004-04-15	Flüssige formulierungen
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
IS6398A (is)	2002-05-27	Lyfjablöndur
DE60123364D1 (de)	2006-11-09	Sterilisierungsmittelverdampfer
ATE268116T1 (de)	2004-06-15	Mesotrion-formulierungen
DE60104126D1 (de)	2004-08-05	Fungizide formulierung
NO20030946D0 (no)	2003-02-28	Medisinske sammensetninger
GB0024711D0 (en)	2000-11-22	Medicinal aerosol formulations
SE0004844D0 (sv)	2000-12-22	Länkhjul
DK1267974T3 (da)	2005-08-01	Inhalationsapparat
GB0007070D0 (en)	2000-05-17	Deodorant formulations

Legal Events

Date	Code	Title	Description
2008-05-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application